Trial record 1 of 16 for:    Viromed
Previous Study | Return to List | Next Study

Phase 3 Gene Therapy for Painful Diabetic Neuropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02427464
Recruitment Status : Recruiting
First Posted : April 28, 2015
Last Update Posted : October 23, 2017
MedTech Consultants Inc.
Information provided by (Responsible Party):
ViroMed Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : June 2019